Home › Borstkanker › Pennsylvania › Philadelphia
Borstkanker klinische studies in Philadelphia, PA
56 studies voor Borstkanker zoeken deelnemers op locaties in en rond Philadelphia (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RekruterenFase 1/2
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
RekruterenFase 3
- Consultants In Med Onco And Hema, Drexel Hill · 7 mijl verwijderd
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Reading Hospital McGlinn Cancer Institute at Phoenixville, Phoenixville · 22 mijl verwijderd
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
RekruterenFase 2
- University of Pennsylvania, Abramson Cancer Center, Perelman Center for Advanced Medicine, Philadelphia
- Alliance Cancer Specialists, Horsham · 16 mijl verwijderd
Study of AVZO-021 in Patients With Advanced Solid Tumors
RekruterenFase 1/2
- Avenzo Therapeutics Recruiting Site, Philadelphia
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
RekruterenFase 3
- Thomas Jefferson University - Clinical Research Institute ( Site 0056), Philadelphia
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
RekruterenFase 3
- Penn Medicine - Perelman Center for Advanced Medicine, Philadelphia
- Penn Medicine - Chester County Hospital, West Chester · 24 mijl verwijderd
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
RekruterenFase 3
- Clinical Trial Site, Horsham · 16 mijl verwijderd
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
RekruterenFase 1
- University of Pennsylvania, Philadelphia
- Fox Chase Cancer Center, Philadelphia
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
RekruterenFase 3
- University of Pennsylvania Hospital, Philadelphia
- Thomas Jefferson University - Clinical Research Institute, Philadelphia
- Jefferson Hospital Northeast, Philadelphia
- en nog 1
Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
RekruterenFase 2
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
RekruterenFase 3
- Fox Chase Cancer Center, Philadelphia
- Lankenau Medical Center, Wynnewood · 7 mijl verwijderd
- Consultants In Medical Oncology and Hematology, P.C., Broomall · 10 mijl verwijderd
- en nog 1
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
RekruterenFase 1/2
- University of Pennsylvania - Abramson Cancer Center, Philadelphia
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
RekruterenFase 1/2
- University of Pennsylvania, Philadelphia
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
RekruterenFase 1
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)
RekruterenObservatieonderzoek
- Abramson Cancer Center, Philadelphia
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RekruterenFase 3
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
- Fox Chase Cancer Center, Philadelphia
- en nog 11
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
RekruterenFase 1
- Sidney Kimmel Comprehensive Center at Jefferson, Philadelphia
PENN-Surveillance Markers of Utility for Recurrence After (Neo)Adjuvant Therapy for Breast Cancer
Rekruteren
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
ATEMPT 2.0: Adjuvant T-DM1 vs TH
RekruterenFase 2
- University of Pennsylvania, Abramson Cancer Center, Philadelphia
Tai Chi for Reducing Aromatase Inhibitor-Induced Arthralgia
Rekruteren
- Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
RekruterenFase 2/3
- Abramson Cancer Center of The University of Pennsylvania, Philadelphia
Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery
Rekruteren
- Fox Chase Cancer Center, Philadelphia
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
RekruterenFase 3
- Sidney Kimmel Comprehensive Cancer Center - Thomas Jefferson University Hospital, Philadelphia
E-Mindfulness Approaches for Living After Breast Cancer
RekruterenFase 3
- UPMC Hillman Cancer Center - Part of Frick Hospital, Mount Pleasant · 8 mijl verwijderd
- Chester County Hospital, West Chester · 24 mijl verwijderd
Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts
RekruterenGezonde vrijwilligers welkom
- Thomas Jefferson University Hospital, Philadelphia
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
RekruterenFase 2
- Thomas Jefferson University, Philadelphia
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
RekruterenFase 1
- Investigative Site #109, Philadelphia
Virtual Mindful After Cancer (MAC) Intervention to Promote Sexual Health for Breast and Gynecologic Cancer Survivors
RekruterenFase 1
- University of Pennsylvania, Philadelphia
- Fox Chase Cancer Center, Philadelphia
A Mixed-Methods Metabolomics Investigation of Lifestyle and Energy Balance During Breast Cancer Survivorship
Rekruteren
- Abamson Cancer Center of the University of Pennsylvania, Philadelphia
ABemacicliB or Abemaciclib and HydroxYchloroquine to Target Minimal Residual Disease in Breast Cancer
RekruterenFase 2
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
RekruterenFase 3
- Rittenhouse Hematology/Oncology, Philadelphia
Identification of Breast Cancer in Breath Samples Using Trained Detection Dogs
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Hospital of the University of Pennsylvania, Philadelphia
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
RekruterenFase 2
- University of Pennsylvania (U Penn), Philadelphia
Window Study of Intratumoral Mitazalimab in Breast Cancer (WINIT-BC)
RekruterenVroege fase 1
- Hospital of the University of Pennsylvania, Philadelphia
Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA)
RekruterenFase 2
- University of Pennsylvania-Abramson Cancer Center, Philadelphia
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
RekruterenFase 2
- University of Pennsylvania-Abramson Cancer Center, Philadelphia
B.Brilliant Revelation Comparision Study
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Pennsylvania Hospital, Center for Breast Imaging, Philadelphia
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
RekruterenFase 3
- Thomas Jefferson University Hospital, Philadelphia
- Fox Chase Cancer Center, Philadelphia
- Jefferson Torresdale Hospital, Philadelphia
- en nog 4
A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer
RekruterenFase 1
- University of Pennsylvania, Philadelphia
Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer
RekruterenFase 2
- University of Pennsylvania, Philadelphia
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
RekruterenFase 1/2
- Thomas Jefferson University, Sidney Kimmel Comprehensive Cancer Center, Philadelphia
EXploring Inflammation and Social deTerminants Study in Breast Cancer Patients
RekruterenObservatieonderzoek
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University, Philadelphia
FES BPET-DBT in Newly Diagnosed Breast Cancer
RekruterenVroege fase 1
- University of Pennsylvania, Philadelphia
Safe and Explainable AI
RekruterenObservatieonderzoek
- Hospital of the University of Pennsylvania, Philadelphia
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
RekruterenFase 1
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
- Fox Chase Cancer Center, Philadelphia
CTNNA1 Familial Expansion Study
RekruterenObservatieonderzoek
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
RekruterenFase 4
- Albert Einstein Healthcare Network, Philadelphia
[18F] F-GLN by PET/CT in Breast Cancer
RekruterenFase 1
- University of Pennsylvania, Philadelphia
Prospective Breast Cancer Biospecimen Collection
RekruterenObservatieonderzoek
- Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
Targeted Palliative Care Intervention for Patients With Metastatic Breast Cancer
Rekruteren
- University of Pennsylvania, Philadelphia
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruterenObservatieonderzoek
- Massive Bio SYNERGY-AI site, Philadelphia
Surviving Daily Life
RekruterenObservatieonderzoek
- Thomas Jefferson University, Philadelphia
The Cancer of the Pancreas Screening-5 CAPS5)Study
RekruterenFase 3
- University of Pennsylvania, Philadelphia
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
RekruterenObservatieonderzoek
- Consultants in Medical Oncology and Hematology, P.C., Broomall · 10 mijl verwijderd
- Alliance Cancer Specialists, Horsham · 16 mijl verwijderd
Role of the Immune Environment in Response to Therapy in Breast Cancer
RekruterenObservatieonderzoek
- Abramson Cancer Center, Philadelphia
Borstkanker studies in andere steden
- New York City, NY136 studies
- Houston, TX126 studies
- Boston, MA112 studies
- Nashville, TN81 studies
- Los Angeles, CA73 studies
- Edison, NJ68 studies
- St. Louis, MO64 studies
- Queens, NY64 studies
- Durham, NC64 studies
- Chicago, IL59 studies
- Dallas, TX55 studies
- San Antonio, TX47 studies
Andere studies in Philadelphia
- Kanker (alle vormen)59 studies
- Niet-kleincellige longkanker51 studies
- Metastatische kanker46 studies
- Prostaatkanker44 studies
- Colorectale kanker44 studies
- Eierstokkanker44 studies
- Longkanker36 studies
- Acute myeloïde leukemie34 studies
- Hartfalen31 studies
- Endometriumkanker28 studies
- Depressie26 studies
- Aldermeesklierkanker26 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.